---

$23.37

+0.0200 ( +0.09% ) 0.0K

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-05-21	Buy	79566.00	SIEGALL CLAY B
2024-05-17	Sale	-30000.00	Rosett Max
2024-01-31	Sale	-175000.00	Rosett Max
2024-01-31	Sale	-200000.00	Stoneman Sandra G.